Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Cytochrome P2B6 on Efavirenz Dose in HIV-infected Thai Patients
NCT02421289Phase 1Unknown
- Sponsor
- Mahidol University
- Start
- Apr 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Mahidol University. Primary endpoint: HIV RNA at 24 weeks. Status: unknown.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02421289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421289.